Oncology
Flowchart Overview
 
1
2
2
3
1
1
2
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
3
4
1
9
CARIBOU-CAMMOUFLAGE-CB-011A-MM Phase I OPEN TO ACCRUAL
CELGENE-GC-LTFU-001 Phase II/III OPEN TO ACCRUAL
GRACELL-GC012F-CD19-BCMA-001 Phase I/II OPEN TO ACCRUAL
GSK-3377794-LTFU Phase I OPEN TO ACCRUAL
IIT-SHAH-IL7-IL15-CD20-19 Phase I/II OPEN TO ACCRUAL
JNJ-MY4002-CARTINUE-LTFU Phase IV OPEN TO ACCRUAL
JUNO-017004-TRANSCEND-CLL Phase I/II OPEN TO ACCRUAL
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
2
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
TRANSTHERA-TT420C2308 Phase III OPEN TO ACCRUAL
1
2
2
3
1
3
1
4
3
2
2
3
1
2
1
2
1
1
1
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
1
2
1
2
3
2
3
3
1
3
1
4
1
2
2
1
1
2
2
1
4
6
1
1
1
NEOGENE-NT-175-201 Phase I OPEN TO ACCRUAL
4
5
1
4
5
1
1
8
ALLIANCE-MM1MDS-A01 Phase II OPEN TO ACCRUAL
ECOG-EA4232 Phase III OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-AKHTAR-CILTA-TALQ Phase I OPEN TO ACCRUAL
INCYTE-INCA035784-101 Phase I OPEN TO ACCRUAL
MODERNA-MRNA-2808-P101 Phase I/II OPEN TO ACCRUAL
SWOG-MM1OA-S03 Phase II OPEN TO ACCRUAL
SWOG-MM1YA-S01 Phase II OPEN TO ACCRUAL
20
3
4
1
3
9
3
7
2
4
4
2
1
1
4
2
2
1
12
4
9
3
2
1
6
1
3
5
4
3
3
3
1
2
2
11
3
2
2
2
3
2
1
POLARIS-2022-001-ARGSARC Phase III OPEN TO ACCRUAL
1
2
3
2
1
1
2
2
1
3
AZ-D516NC00001-TROPION-LUNG14 Phase III OPEN TO ACCRUAL *
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
NEOGENE-NT-112-301 Phase I OPEN TO ACCRUAL
3
8
1
8
4
7
CARNABIOSCIENCES-C1763102 Phase I OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3201-343 Phase I OPEN TO ACCRUAL
DAIICHI-SANKYO-DS3939-077 Phase I/II OPEN TO ACCRUAL
ICHNOS-ISB-2001-101 Phase I OPEN TO ACCRUAL
IIT-GORE-REDIRICT Phase II OPEN TO ACCRUAL
STEMLINE-MEN2312-01 Phase I OPEN TO ACCRUAL
TEVA-TV56278-ONC-10203 Phase I OPEN TO ACCRUAL
12
11
4
2
2
1
1
2
4
3
3
3
1
3
3
1
3
3
1
3
3
1
3
3
1
2
2
1
1
6
3
3
1
1
1
1
2
1
1
8
1
2
4
2
7
5
6
6
2
2
10
1
7
1
IIT-GEORGE-I-PREDICT Phase I/II OPEN TO ACCRUAL
1
ALLIANCE-A151804 Phase N/A OPEN TO ACCRUAL